129 related articles for article (PubMed ID: 31350074)
1. Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
Corso G; Sacchini V; Pravettoni G; Veronesi P; Bonanni B
Eur J Surg Oncol; 2019 Oct; 45(10):1760-1761. PubMed ID: 31350074
[No Abstract] [Full Text] [Related]
2. Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations.
Corso G; De Scalzi A; Feroce I; Veronesi P; Bonanni B; Galimberti V
Per Med; 2018 May; 15(3):153-155. PubMed ID: 29745790
[No Abstract] [Full Text] [Related]
3. CDH1 germline mutations and hereditary lobular breast cancer.
Corso G; Intra M; Trentin C; Veronesi P; Galimberti V
Fam Cancer; 2016 Apr; 15(2):215-9. PubMed ID: 26759166
[TBL] [Abstract][Full Text] [Related]
4. αE-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.
de Groot JS; Ratze MA; van Amersfoort M; Eisemann T; Vlug EJ; Niklaas MT; Chin SF; Caldas C; van Diest PJ; Jonkers J; de Rooij J; Derksen PW
J Pathol; 2018 Aug; 245(4):456-467. PubMed ID: 29774524
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.
Xie ZM; Li LS; Laquet C; Penault-Llorca F; Uhrhammer N; Xie XM; Bignon YJ
Cancer; 2011 Jul; 117(14):3112-7. PubMed ID: 21271559
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and outcome in CDH1-mutant lobular breast cancer.
Corso G; Veronesi P; Sacchini V; Galimberti V
Eur J Cancer Prev; 2018 May; 27(3):237-238. PubMed ID: 29595757
[No Abstract] [Full Text] [Related]
8. Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.
Schrader KA; Masciari S; Boyd N; Salamanca C; Senz J; Saunders DN; Yorida E; Maines-Bandiera S; Kaurah P; Tung N; Robson ME; Ryan PD; Olopade OI; Domchek SM; Ford J; Isaacs C; Brown P; Balmana J; Razzak AR; Miron P; Coffey K; Terry MB; John EM; Andrulis IL; Knight JA; O'Malley FP; Daly M; Bender P; ; Moore R; Southey MC; Hopper JL; Garber JE; Huntsman DG
J Med Genet; 2011 Jan; 48(1):64-8. PubMed ID: 20921021
[TBL] [Abstract][Full Text] [Related]
9. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast.
Chan JK; Wong CS
Adv Anat Pathol; 2001 May; 8(3):165-72. PubMed ID: 11345240
[No Abstract] [Full Text] [Related]
10. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
[TBL] [Abstract][Full Text] [Related]
11. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
[TBL] [Abstract][Full Text] [Related]
12. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
14. CDH1 germline mutations in families with hereditary lobular breast cancer.
Girardi A; Magnoni F; Vicini E; Kouloura A; La Vecchia C; Veronesi P; Corso G
Eur J Cancer Prev; 2022 May; 31(3):274-278. PubMed ID: 33990097
[TBL] [Abstract][Full Text] [Related]
15. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract][Full Text] [Related]
16. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
Corso G; Figueiredo J; La Vecchia C; Veronesi P; Pravettoni G; Macis D; Karam R; Lo Gullo R; Provenzano E; Toesca A; Mazzocco K; Carneiro F; Seruca R; Melo S; Schmitt F; Roviello F; De Scalzi AM; Intra M; Feroce I; De Camilli E; Villardita MG; Trentin C; De Lorenzi F; Bonanni B; Galimberti V
J Med Genet; 2018 Jul; 55(7):431-441. PubMed ID: 29929997
[TBL] [Abstract][Full Text] [Related]
17. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.
Keller G; Vogelsang H; Becker I; Hutter J; Ott K; Candidus S; Grundei T; Becker KF; Mueller J; Siewert JR; Höfler H
Am J Pathol; 1999 Aug; 155(2):337-42. PubMed ID: 10433926
[TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.
Rahman N; Stone JG; Coleman G; Gusterson B; Seal S; Marossy A; Lakhani SR; Ward A; Nash A; McKinna A; A'Hern R; Stratton MR; Houlston RS
Br J Cancer; 2000 Feb; 82(3):568-70. PubMed ID: 10682667
[TBL] [Abstract][Full Text] [Related]
19. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I
Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
